Delivery Order SPE2DB22D9367-SPE2DB24FSY62

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 award is for the provision of NUCALA 100 MG/ML AUTO-INJECTORML pharmaceutical products to support the recurring medical supply needs of military health facilities. This delivery order is issued against a larger, single-award indefinite delivery contract (IDC) valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 contract is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 contract is for the delivery of NUCALA 100 MG/ML AUTO-INJECTOR to support the recurring medical supply needs of military healthcare facilities. The award is issued under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $3,785.80 and covers the delivery of NUCALA 100 MG/ML auto-injectors to support the medical supply needs of military health facilities worldwide. The order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $15,143.20, is for the supply of NUCALA 100 MG/ML AUTO-INJECTORS to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,571.60 contract is for the delivery of NUCALA 100 MG/ML auto-injectors to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,785.80 firm fixed-price contract is for the provision of NUCALA 100 MG/ML auto-injectors to support the recurring medical supply needs of military health facilities. This award is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 firm fixed-price contract is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORS to support the recurring pharmaceutical needs of military health facilities. The order was placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 contract is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a specialty medication, to support the recurring medical needs of military health facilities worldwide. The award is part of a larger single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSY62
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 contract is for the delivery of NUCALA 100 MG/ML auto-injectors to support the recurring medical supply needs of military health facilities.

This award is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the medical requirements of Department of Defense (DoD) healthcare facilities worldwide. The contract does not have a set-aside designation.

Generated 10/8/24, 9:02 AM